2021
DOI: 10.1177/2516865721989719
|View full text |Cite
|
Sign up to set email alerts
|

Relationships among Inorganic Arsenic, Nutritional Status CpG Methylation and microRNAs: A Review of the Literature

Abstract: Inorganic arsenic is a naturally occurring toxicant that poses a significant and persistent challenge to public health. The World Health Organization has identified many geographical regions where inorganic arsenic levels exceed safe limits in drinking water. Numerous epidemiological studies have associated exposure to inorganic arsenic with increased risk of adverse health outcomes. Randomized clinical trials have shown that nutritional supplementation can mitigate or reduce exacerbation of exposure-related e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 91 publications
(194 reference statements)
1
2
0
Order By: Relevance
“…Our observation that arsenic exposure reduced hepatic CYP7B1 is consistent with previous studies with various arsenic doses in mice [45][46][47]. CYP7B1 is one of the cytochrome P450 (CYP) monooxygenases that is involved in the biosynthesis of bile acids, oxysterols, and steroid hormones by consuming cholesterol.…”
Section: Discussionsupporting
confidence: 92%
“…Our observation that arsenic exposure reduced hepatic CYP7B1 is consistent with previous studies with various arsenic doses in mice [45][46][47]. CYP7B1 is one of the cytochrome P450 (CYP) monooxygenases that is involved in the biosynthesis of bile acids, oxysterols, and steroid hormones by consuming cholesterol.…”
Section: Discussionsupporting
confidence: 92%
“…Despite the abundant literature on the toxicity of arsenic [273][274][275] and the existing regulatory measures taken by numerous agencies (e.g., maximum drinking water contamination level of 10 µg/L (10 ppb or 0.13 µM) set by the World Health Organization and US-EPA [276]), the toxicity of this metal is still an important risk assessment research topic. This is because: (1) it is present naturally in the environment and as waste in mining industries [277], (2) inorganic arsenic levels exceed safe limits in drinking water in more than 50 countries [278], (3) reasons for interindividual disease susceptibility to arsenic must be understood [278], (4) mitigation [278] or remediation nutritional supports are required for the exposed population [273], and (5), understanding the extent of genotoxic and non-genotoxic mechanisms contributing to its carcinogenic mode of action is important given that this might influence regulatory measures and treatment intervention for correctable non-genotoxic epigenetic anomalies. Finally, numerous epigenetic anomalies described in the following paragraphs and in the Supplementary Tables S2 and S3 occur at physiologically relevant concentrations (human whole-blood levels of total arsenic range from 0 to 46.5 µg/L or 0.6 µM) [279].…”
Section: Arsenicalsmentioning
confidence: 99%
“…There are sex differences in the one-carbon metabolism pathway generating SAM necessary to methylate arsenicals [321], such that men are at a higher risk of developing skin lesions due to the lower methylation rate of MMA to DMA [322]. Differences in arsenic metabolism, nutrition and micronutrients (e.g., methionine, choline, folate, betaine, and vitamin B12) are known to affect DNAm [273,321]. Timing of sampling relative to exposure and disease status may also influence detection of associations.…”
Section: Human Blood Measurements Confounding Factorsmentioning
confidence: 99%